Impact of Managed Care on the Treatment of Atrial Fibrillation

This publication has 21 references indexed in Scilit:

• Management of Patients With Atrial Fibrillation
  Circulation, 1996
• Comparison of the safety and efficacy of flecamide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter
  The American Journal of Cardiology, 1996
• Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias
  European Heart Journal, 1995
• Effects of Prophylactic Antiarrhythmic Drug Therapy in Acute Myocardial Infarction
  JAMA, 1993
• Management of Atrial Fibrillation
  New England Journal of Medicine, 1992
• Propafenone Treatment of Symptomatic Paroxysmal Supraventricular Arrhythmias
  Annals of Internal Medicine, 1991
• Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: Dose-response studies
  Journal of the American College of Cardiology, 1991
• Clinical and regulatory implications of the cardiac arrhythmia suppression trial
  The American Journal of Cardiology, 1990
• Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
  Circulation, 1989
• The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio
  American Heart Journal, 1989